COVID-19 infection associated with increased risk of developing Guillain-Barré syndrome

Having a COVID-19 infection is associated with an increased risk of developing the rare disorder called Guillain-Barré syndrome within the next six weeks, according to a study published in the October 18, 2023, online issue of Neurology, the medical journal of the American Academy of Neurology.

Researchers uncover the role of glutaminase 2 in glucose homeostasis

Glutaminase 2 (GLS2) is a master regulator of glutaminolysis. GLS2 converts glutamine to glutamate, thereby playing a role in cellular energy production. GLS2 is abundant

July 5, 2023

Merck’s Welireg wins label expansion in kidney cancer despite missing survival data

Merck’s Welireg won a label expansion on Thursday in a common form of kidney cancer, weeks ahead of its decision date and without a clear

December 16, 2023

Exclusive: A longtime VC takes on his own rare disease as Sanofi, Boehringer commit $80M to launch new platform study

Over three decades of investing, Luke Evnin has backed and advised dozens of biotechs developing medicines. Now, the longtime VC is turning his know-how and

December 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.